Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1200 of 3546 entries
View as:

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01691859 Org: User:
Start: 09/28/12 End: 05/31/17 Due: 05/31/18

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01626820 Org: User:
Start: 07/19/12 End: 08/10/12 Due: 08/10/13

An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB)

Phase: N/A Priority: Normal
NCT ID: NCT01205165 Org: User:
Start: 12/17/04 End: 04/28/06 Due: 04/28/07

A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH)

Phase: N/A Priority: Normal
NCT ID: NCT03177603 Org: User:
Start: 02/21/18 End: 05/07/19 Due: 05/07/20

A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01316887 Org: User:
Start: 01/01/11 End: 07/21/12 Due: 07/21/13

A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00678977 Org: User:
Start: 04/03/08 End: 06/30/11 Due: 06/30/12

Bioequivalence of GW483100 10 Milligram (mg) Tablets in Healthy Subjects Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02658422 Org: User:
Start: 08/18/15 End: 09/21/15 Due: 09/21/16

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of GSK573719 (LAMA) and GW642444 (LABA)Administered Individually and Concurrently in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00976144 Org: User:
Start: 07/29/09 End: 09/22/09 Due: 09/22/10

A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol With Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01879410 Org: User:
Start: 06/13/13 End: 01/09/14 Due: 01/09/15

Study in Pediatric Subjects With Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT01494584 Org: User:
Start: 07/25/12 End: 04/29/13 Due: 04/29/14

Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-centre, Dose Ranging Study to Evaluate the Efficacy and Safety of Losmapimod Tablets Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD).

Phase: N/A Priority: Normal
NCT ID: NCT01218126 Org: User:
Start: 11/04/10 End: 12/21/11 Due: 12/21/12

Japanese Phase 1 Study of GSK2585823

Phase: N/A Priority: Normal
NCT ID: NCT01428466 Org: User:
Start: 11/18/10 End: 02/15/11 Due: 02/15/12

Clinical Study Of Migraine Evolution

Phase: N/A Priority: Normal
NCT ID: NCT00460005 Org: User:
Start: 01/31/06 End: - Due: -

Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotavirus (RV) Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT01682005 Org: User:
Start: 08/31/12 End: 08/31/13 Due: 08/31/14

Influenza Burden Assessment in the United States, July1997 - up to April 2009

Phase: N/A Priority: Normal
NCT ID: NCT01599390 Org: User:
Start: 07/31/12 End: 02/28/13 Due: 02/28/14

A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00955773 Org: User:
Start: 08/17/09 End: 11/08/11 Due: 11/08/12

A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV

Phase: N/A Priority: Normal
NCT ID: NCT00082394 Org: User:
Start: 04/26/04 End: 03/01/06 Due: 03/01/07

Dyslipidemia Study Investigating The Increase In "Good Cholesterol"

Phase: N/A Priority: Normal
NCT ID: NCT00169559 Org: User:
Start: 11/30/03 End: 04/30/05 Due: 04/30/06

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Phase: N/A Priority: Normal
NCT ID: NCT01702454 Org: User:
Start: 10/06/12 End: 06/05/13 Due: 06/05/14

A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT02485301 Org: User:
Start: 07/15/15 End: 12/23/16 Due: 12/23/17

Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01124422 Org: User:
Start: 07/19/10 End: 05/02/11 Due: 05/02/12

Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02229240 Org: User:
Start: 08/31/15 End: 12/31/15 Due: 12/31/16

A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00938158 Org: User:
Start: 08/05/09 End: 04/12/11 Due: 04/12/12

Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT03345407 Org: User:
Start: 11/28/17 End: 01/10/19 Due: 01/10/20

Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza

Phase: N/A Priority: Normal
NCT ID: NCT02927431 Org: User:
Start: 01/19/17 End: 05/24/17 Due: 05/24/18